by John Conrad | Jan 12, 2023 | Member News
In the wake of Evozyne’s hiring of a seasoned tech-company executive as CEO, the Chicago-based biotech company announced it’s developed an AI model that it hopes will revolutionize development of new therapeutic proteins, significantly accelerating the...
by John Conrad | Oct 31, 2022 | iBIO in the News
Illinois’ bioscience industry has seen major growth in recent years as government grants and private investors have pumped money into the sector, according to a new report. But a shaky economy and venture-capital slowdown this year will likely hamstring...
by John Conrad | Oct 17, 2022 | iBIO in the News
Amid waning venture-capital activity in Illinois and across the country this year as macroeconomic conditions deter investors from cutting checks to startup companies, health care businesses appear to be attracting the most investor interest. Of the 10 largest VC...
by John Conrad | Sep 19, 2022 | iBIO in the News
Although Chicago is the third largest city in the United States, when it comes to its position as a leading biotech hub, the second city ranks far below many other U.S. locations. That is starting to change, however, as new companies move into this heart of...
by John Conrad | Aug 3, 2022 | iBIO in the News
llinois is recognized as a national leader in the life sciences industry, which employs more than 41,000 people across the state. A 2019 report found the overall economic output of the life sciences industry in Illinois was $98 billion, with pharmaceutical research...
